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Naturally occurring hypoadrenocorticism is a relatively rare endocrine disorder in the dog. 
The vast majority of cases suffer from primary hypoadrenocorticism which is also known 
as Addison’s disease (AD). It is currently assumed that the main cause is autoimmune 
destruction of the adrenal cortex. At least 90% of adrenocortical tissue has to be destroyed 
before clinical signs become apparent. In immune mediated AD tissue loss usually takes 
place in a slow and progressive manner over weeks to months. Typically, the destruction 
involves all three zones of the adrenal cortex and results in deficiency of both cortisol and 
aldosterone. Cortisol is required in almost all tissues of the body and its deficiency is 
associated with stress intolerance, weakness, gastrointestinal signs, hypotension, absence 
of a stress leucogram, anemia and hypoglycemia. Aldosterone acts mainly on the renal 
tubule to increase the absorption of Na+ and Cl- and the secretion of K+ and H+. 
Aldosterone deficiency therefore is typically characterized by variable degrees of 
hyperkalemia, metabolic acidosis and hyponatremia; sodium wasting in turn is associated 
with volume depletion. In primary hypoadrenocorticism, endogenous ACTH is highly 
elevated due to the negative feedback. Secondary hypoadrenocorticism is due to ACTH 
deficiency (either direct or due to reduced CRH secretion) and has so far only rarely been 
described in dogs. It may result from destructive lesions in the pituitary or hypothalamus, 
such as neoplasia, inflammation, trauma or lymphocytic hypophysitis. Aldosterone 
secretion should not be impaired, as it is mainly regulated by the RAA system and the 
plasma potassium concentration. Differentiation between primary and secondary 
hypoaldosteronism is critical as the latter requires further workup (e.g. brain imaging) and 
prognosis may be guarded. 
In primary hypoadrenocorticism (AD), the typical or classical electrolyte abnormalities are 
hyperkalemia and/or hyponatremia, which occur 80 – 90% of cases. Severity of the 
electrolyte alterations ranges from subtle to very severe and life-threatening. It should be 
remembered that although hyponatremia and hyperkalemia are often seen in dogs with AD 
they are not specific for the disease. They may for instance be found in dogs with primary 
gastrointestinal diseases (most frequently associated with diarrhoea from trichuris 
infection), cortisol and aldosterone concentrations are not affected in those cases.  
In about 10% of dogs with AD both sodium and potassium concentrations are within the 
normal range, which has been referred to as atypical AD. In those dogs diagnosis may be 
delayed because the typical electrolyte changes are lacking and therefore the index of 
suspicion is low. When dogs with typical and atypical AD were compared, the latter were 
older at the time of diagnosis and had a longer duration of clinical signs which highlights 
the fact that the disease may go undetected for longer periods. It has been postulated that 
in dogs with atypical AD the destructive (e.g. immune-mediated) process is confined to the 
zona fasciculate and zona reticularis, leading to an isolated glucocorticoid deficiency with 
intact aldosterone secretion. However, so far only very few data are available to confirm 
this assumption. In most studies describing dogs with atypical AD diagnosis was based on 
the demonstration of low cortisol concentrations after administration of synthetic ACTH. 
Aldosterone concentrations unfortunately were rarely measured; the finding of normal 
electrolytes just lead to the assumption that aldosterone was also normal. In human 
medicine normal sodium and potassium concentrations are seen in approximately 10% of 
patients with AD, similar to the situation in dogs. For quite some time it was also believed 
that the zona glomerulosa is intact, however this assumption has recently been degraded. 
Dissociation between zona glomerulosa and zona fasciculate/reticularis function seems to 
occur in fact only very rarely in humans with AD. We recently investigated cortisol and 
aldosterone concentrations pre and post ACTH (i.e. during an ACTH stimulation test) in 19 
healthy dogs, 22 dogs with diseases mimicking AD and in 70 dogs with AD. Healthy dogs 
and dogs with mimicking diseases showed a significant increase in cortisol and 
aldosterone concentration post ACTH, whereas neither cortisol nor aldosterone increased 
in the dogs with AD. Interestingly, 67 of the 70 dogs with AD had low-undetectable 
aldosterone concentrations independent of the degree of electrolyte abnormalities, e.g. 
dogs with mild and dogs with severe abnormalities had similar low aldosterone 
concentrations. In 4 dogs with AD the typical electrolyte abnormalities were lacking, e.g. 
they suffered atypical AD. The striking finding was that in all 4 dogs post-ACTH 
aldosterone concentrations were below the detection limit, meaning that they were able to 
maintain their electrolytes in the normal range without aldosterone. Our results 
demonstrate that normal electrolytes do not necessarily reflect a normally functioning zona 
glomerulosa. It is therefore possible that in dogs with atypical AD not only the zona 
fasciculate/reticularis but also the zona glomerulosa is damaged and other mechanisms 
(most likely intrarenal) help to maintain a normal electrolyte balance. 
However, there may be exceptions. Histologic evidence of partially spared zona 
glomerulosa has been described in a small number of dogs with atypical AD, unfortunately 
aldosterone was not measured. Dogs with typical AD should be treated with gluco- and 
mineralocorticoids. In dogs with atypical AD treatment may initially be limited to the 
administration of glucocorticoids. However, close monitoring is of great importance as 
electrolyte abnormalities (and the need for additional mineralocorticoid replacement) may 
occur at any time during the course of disease.  
With regard to work-up of cases the following points are important to remember: 
- Acute renal failure and AD may look alike as the latter often times is associated with 
azotemia and urine specific gravity < 1.020. Whenever azotemia is found in an acutely 
ill dog, the possibility of AD should be considered.  
- Most dogs with AD reveal typical electrolyte abnormalities. Hyponatremia and/or 
hyperkalemia should however not be equalized with the diagnosis of AD, as various 
other diseases can be associated with similar findings. Confirmation of AD requires the 
documentation of a low cortisol concentration after ACTH administration. A post-ACTH 
cortisol < 55 nmol/l is an inadequate response and consistent with AD, most dogs with 
acute AD will have post ACTH cortisol concentrations < 27 nmol/l. In those cases 
(confirmed AD with electrolyte abnormalities) additional measurement of aldosterone 
gives no further information. 
- Some dogs with AD have normal sodium and normal potassium concentrations (atypical 
AD). A high index of suspicion is needed as the clinical presentation is unspecific. We 
routinely measure the baseline cortisol concentration in any dog with unclear disease. A 
baseline cortisol concentration > 55 nmol/l excludes the presence of AD, if cortisol is < 
55 nmol/l an ACTH stimulation test is performed. In cases with confirmed atypical AD 
additional measurement of aldosterone may be helpful to determine the extent of zona 
glomerulosa impairment. Close monitoring of those dogs is of utmost importance. 
- To differentiate between atypical AD and secondary hypoadrenocorticism endogenous 
ACTH should be measured (high in case of (atypical) AD, low in case of secondary 
hypoadrenocorticism). It is currently not known if differentiation can reliably be done by 
means of aldosterone measurement.  
- Diagnosis of hypoadrenocorticism is notoriously difficult in dogs which have received 
glucocorticoids as cortisol levels may be similarly low. Abnormal electrolytes would 
support the diagnosis of AD. If electrolytes abnormalities are missing, measurement of 
endogenous ACTH is often not helpful as it may be increased in dogs with atypical AD 
as well after cessation of glucocorticoid treatment.  
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